The Rubicon Research IPO has created quite a buzz in the Indian stock market. With its subscription window closing on October 13, 2025, investors are now eagerly waiting for the allotment status. If you’re wondering how to check whether you got shares, what the overall subscription was, or when the company will list, you’re in the right place. This guide will take you through the entire process, including subscription insights, online allotment checking methods, and tips for first-time IPO investors.
Rubicon Research IPO Allotment Status: Check Overall Subscription & Steps to Verify Status
Have you applied for the Rubicon Research IPO? Curious if you’re among the lucky allottees? Let’s dive into the step-by-step process for checking your IPO allotment:
What is the Rubicon Research IPO Allotment Status?
In simple terms, the IPO allotment status is the confirmation that tells investors whether their application for shares has been successful. It’s a crucial step after the IPO subscription closes. For Rubicon Research, this status will determine who gets shares before the company hits the stock exchanges.
Procedure to Check Rubicon Research IPO Allotment Status Online on BSE
Here’s how you can quickly verify your allotment through BSE:
- Visit the BSE IPO application status page here.
- Select “Equity” in Issue Type.
- Choose “Rubicon Research Ltd” as Issue Name.
- Enter your Application Number or PAN Number.
- Complete the CAPTCHA verification.
- Click Submit.
Voila! You’ll immediately see your allotment result.
Procedure to Check Rubicon Research IPO Allotment Status Online on NSE
For NSE users, follow these steps:
- Navigate to the NSE IPO allotment verification page.
- Select “Equity & SME IPO bid details”.
- Choose Rubicon Research Ltd as the symbol.
- Enter your PAN Number and Application Number.
- Click Submit.
This method ensures you get your status directly from NSE’s official portal.
Procedure to Check Rubicon Research IPO Allotment Status via MUFG Intime India Pvt Ltd
The registrar MUFG Intime provides another reliable way:
- Visit the MUFG Intime IPO status page.
- Under “Please select company,” choose Rubicon Research Ltd.
- Enter any one of these details: PAN, Application Number, DP/Client ID, or Account No/IFSC.
- Click Submit.
This option is helpful if you prefer checking allotment through the registrar directly.
Rubicon Research IPO Overall Subscription Status
As of October 13, 2025, the Rubicon Research IPO subscription numbers are eye-popping:
| Investor Category | Subscription Multiplier |
|---|---|
| Retail Individual Investors (RIIs) | 37.40x |
| Non-Institutional Investors (NIIs) | 102.70x |
| Employees | 17.68x |
| Qualified Institutional Buyers (QIBs) | 137.09x |
| Overall | 109.35x |
Clearly, the IPO was heavily oversubscribed, reflecting strong investor confidence in Rubicon Research.
Rubicon Research Ltd – IPO Details
Let’s break down the IPO specifics:
- Total Issue Size: ₹1,377.50 crores
- Fresh Issue: 1.03 crore shares (~₹500 crores)
- Offer for Sale: 1.81 crore shares (~₹877.50 crores)
- Price Band: ₹461–₹485 per share
- Minimum Lot Size: 30 shares (~₹13,830 for retail investors)
Book-Running Lead Managers: Axis Capital Ltd, IIFL Capital Services Ltd, JM Financial Ltd, SBI Capital Markets Ltd
Registrar: MUFG Intime India Pvt Ltd
Tentative Listing Date
The Rubicon Research IPO is expected to list on October 16, 2025, on both BSE and NSE. Investors should monitor market trends as IPO listings often see volatility in the first few days.
Why Investors Are Eyeing Rubicon Research IPO?
Rubicon Research is a specialty pharmaceuticals company focusing on IP-led products, including oral solids, injectables, ophthalmic, nasal & inhalation forms. Founded in 1999 and headquartered in Thane, India, the company has R&D centers in Thane and Concord (Canada) and manufacturing plants in Ambernath and Satara, India.
Financial Highlights FY2025:
- Revenue: ₹1,296.2 crore (up 48.5% from FY2024)
- Profit After Tax (PAT): ₹134.36 crore
- EBITDA: ₹267.9 crore (margin 20.7%)
This growth trajectory has fueled investor interest and heavy oversubscription.
Bookbuilding Mechanism Explained
The Rubicon Research IPO used the bookbuilding method, a standard in India where institutional investors set the price range. Retail investors can apply within this band. Bookbuilding ensures market-driven pricing and better allocation efficiency.
How Many Shares Did Retail Investors Get?
Given the oversubscription (37.40x for retail), allotment will likely be proportionally reduced. Investors should check their status online as per the procedures above.
Role of Qualified Institutional Buyers (QIBs)
QIBs subscribed 137.09x, the highest among all categories. These are large financial institutions, mutual funds, and foreign portfolio investors that significantly influence IPO success.
Non-Institutional Investors (NIIs) Subscription
NIIs, often high-net-worth individuals, subscribed 102.70x, showing massive appetite among wealthier investors who typically invest larger sums.
Employee Reservation Category
Rubicon Research allocated shares to employees, who subscribed 17.68x, reflecting internal confidence in the company’s growth.
Steps for First-Time IPO Investors
- Open a Demat account.
- Link your bank account.
- Submit IPO application online through your broker.
- Track subscription numbers daily.
- Check allotment status post subscription.
Common Mistakes While Checking IPO Status
- Using incorrect PAN/Application numbers
- Ignoring the CAPTCHA verification
- Trying unofficial portals for verification
- Not noting the lot size and minimum application criteria
Always use official sources like BSE, NSE, or MUFG Intime.
What Happens After IPO Allotment?
- Refunds are processed for unsuccessful applicants.
- Allotted shares get credited to your Demat account.
- You can start trading from the listing date.
How to Track Refunds?
If your application wasn’t fully allotted:
- Check your bank account linked to IPO application.
- Track through BSE/NSE allotment pages.
- Refunds are typically credited 2–5 business days after allotment.
Understanding Oversubscription Impact
Oversubscription indicates demand exceeds supply, often leading to grey market premiums. While retail investors get shares proportionally, QIBs and NIIs dominate the allocation.
Rubicon Research IPO Price Band and Valuation
The ₹461–₹485 price band suggests a market valuation of approximately ₹1,377.5 crores, aligning with financial growth and investor appetite.
Investment Strategy Post-IPO
- Short-term traders may capitalize on listing-day price movements.
- Long-term investors focus on fundamentals, R&D pipeline, and market expansion.
Risks Involved
- Market volatility at listing
- Company-specific operational risks
- Regulatory approvals for pharma products
Diversification and thorough research are key.
How to Use Allotment Status Data?
- Plan your trading strategy
- Forecast demand in secondary market
- Track investment allocation efficiency
Regulatory Oversight
- IPOs in India are regulated by SEBI (Securities and Exchange Board of India).
- Ensures fair allotment and transparent pricing.
Role of Book Running Lead Managers
- Guide IPO process
- Set price band
- Manage subscriptions and allocation
- Ensure compliance with SEBI norms
Registrar’s Role in IPO
MUFG Intime India Pvt Ltd handles:
- Application processing
- Verification of details
- Allocation of shares
- Refunds to unsuccessful applicants
Investor Tips
- Always check official portals for updates
- Keep PAN and application details handy
- Understand the minimum lot size
- Monitor market trends pre-IPO listing
How to Explore Other Upcoming IPOs?
- Visit BSE IPO section
- Visit NSE IPO section
FAQs About Rubicon Research IPO Allotment Status
Q1: When will the Rubicon Research IPO allotment be finalized?
A1: The allotment is expected to be finalized on October 14, 2025.
Q2: How can I check my allotment if I applied online?
A2: You can check via BSE, NSE, or MUFG Intime India Pvt Ltd using your PAN or application number.
Q3: What was the overall subscription for Rubicon Research IPO?
A3: The IPO was 109.35 times oversubscribed, with different investor categories showing varying levels of demand.
Q4: What is the minimum lot size for retail investors?
A4: The minimum lot size is 30 shares, costing around ₹13,830 at the upper price band.
Q5: When will Rubicon Research list on BSE and NSE?
A5: The tentative listing date is October 16, 2025.
Q6: Who were the lead managers for this IPO?
A6: Axis Capital Ltd, IIFL Capital Services Ltd, JM Financial Ltd, and SBI Capital Markets Ltd.
Conclusion
The Rubicon Research IPO has been a stellar success, attracting enormous investor interest. Tracking the allotment status is now the next crucial step. By following official procedures through BSE, NSE, or MUFG Intime, investors can ensure they stay updated. With strong fundamentals, expanding R&D, and promising financial performance, Rubicon Research shares are expected to generate keen interest on the listing date. Stay informed, act wisely, and make the most of your IPO investment.
